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Introduction 
Abnormalities in pulmonary surfactant phospho- 
lipids from patients with idiopathic pulmonary 
fibrosis (IPF) correlate with the nature of the 
histopathological and clinical impairment (1). This 
report presents the recovery of cholesterol crystals in 
the bronchoalveolar lavage (BAL) fluid in two cases 
of IPF. This evidence may suggest the direct involve- 
ment of cholesterol crystals in tissue damage or of 
their being a marker for altered composition of lung 
lining fluid. 
Patients and Methods 
Two patients suffering from severe IPF were 
studied. Patient 1 was a 62-year-old male who was a 
non-smoker and who had had progressive dyspnoea 
since 1991. There was no clubbing, but crepitations 
were present at both lung bases. X-rays and 
computerized topographic (CT) scanning of the 
chest showed widespread bilateral interstitial 
changes. 
Patient 2 was a 45-year-old male, also a non- 
smoker, who had had progressive dyspnoea and a 
non-productive cough since 1986. Clubbing was 
present and crepitant rales were audible at both lung 
bases. Chest X-rays showed reticular interstitial 
infiltrates. Transbronchial biopsies yielded lung 
tissue with mural thickening and intra-alveolar 
fibrinous exudate. Some bronchioles and alveolar 
ducts had become obliterated while others were only 
disrupted. These compensatory dilatations produced 
a typical honeycomb appearance. The fibrotic tissue 
and the honeycombed area formed a hyperplastic or 
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metaplastic epithelial cover of the airspaces. All 
these findings were consistent with the diagnosis of 
pulmonary fibrosis. 
Neither patient was treated before BAL. Pulmon- 
ary function tests (PFT) were done using a spirometer 
and a body plethysmograph (MasterLAb-Herich, 
Jaeger GmbH Co., KG, Germany). Bronchoalveolar 
lavage was performed by conventional methods 
(2). The recovered fluid was processed as described 
previously (3). 
Fluorcytometric analysis was performed on a 
scanner (Fat-Scan) with an Ar+ laser (Becton- 
Dickinson) as described previously (4). Cells were 
pelleted (2 ml of solution, lo6 cells ml - ‘) and lipid 
extraction was performed according to Folch et al. 
(5). For the analysis of cholesterol and phospho- 
lipids, the methods of Abbe1 et al. (6) and Bartlett (7) 
were used. Light and light-polarized microscopy 
(Olympus Optical Co. Ltd, Tokyo, Japan) were 
used to perform the morphological identification of 
crystals. Two control subjects were included; non- 
smokers who underwent bronchoscopy due to per- 
sistent cough with no X-ray or clinical evidence of 
interstitial lung disease. 
Results 
Pulmonary function tests showed a severe restric- 
tive impairment (TLC=50% of predicted in both 
patients) and reduction of DLCO (Patient 1=46% 
and Patient 2 = 25% of predicted). Differential counts 
of cells yielded a high percent of neutrophils (Patient 
1 = 18% and Patient 2~35%) with mild lymphocytosis 
(Patient 1=32% and Patient 2=22%). There was a 
differential pattern of T-cell subsets; the helper/ 
suppressor ratio was above the normal range (3.9) 
in Patient 1, while it was low (0.8) in Patient 2. 
Cholesterol crystals were recovered from the BAL 
fluid from each patient. Ghosts of some symmetric 
extracellular structures were initially identified by a 
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Table I Phospholipid and cholesterol content of BAL cells 
Plate I Ghosts of some symmetric extracellular structures 
first identified by Giemsa stained cytospin slides. Foamy 
macrophages were also seen. 
Plate 2 The same structures as in Plate 1 were finally 
identified as being cholesterol crystals using a fresh 
preparation with a polarized light microscope. 
Giemsa stain cytoprep (Plate I), and finally identified 
as being cholesterol crystals by fresh preparation 
with a polarized light microscope (Plate 2). Foamy 
macrophages were present in specimens from both 
patients (Plate 1). 
The phospholipid and cholesterol contents from 
the pellets formed by the BAL cells are detailed in 
Tale 1. When the results were compared with those of 
the controls, the levels of cholesterol and other 
phospholipids from both patients were found to be 
significantly higher. 
Discussion 
The data presented in this report show the presence 
of cholesterol crystals in the BAL of two patients 
with a clinical course and histological findings com- 
patible with IPF. The percent neutrophils in BAL 
Phospholipids Cholesterol 
GM) Cm@ 
Patient 1 1.3 0.307 
Patient 2 0.5 0.282 
Control l* 0.16 0.066 
Control 2* 0.16 0.070 
*Determinations of phospholipids and cholesterol were 
performed in BAL cells of two patients who underwent 
bronchoscopy due to persistent cough (foreign body). 
cells was high, but a different pattern was seen in the 
lymphocyte subsets. Patient 1 had a high percent of 
CD4+ cells, while Patient 2 had a high percent of 
CD8’ cells. These findings were compatible with the 
authors’ earlier conclusions (4) that a high or normal 
percentage of helper T-lymphocytes in BAL of 
fibrotic patients correlates with a better response to 
corticosteroid therapy. In fact, the DLCO capacity of 
Patients 1 improved by 25% after treatment with 
corticosteroids, although Patient 2 did not improve 
(data not shown). 
The bronchoalveolar cells extract obtained from 
both patients showed a high content of cholesterol 
and other phospholipids. This material consisted of 
pulmonary surfactants and a complex mixture of 
cells including macrophages, lymphocytes and their 
secretory product. Studies on this lining fluid in 
humans (8) revealed it to have suppressive effects on 
lymphocyte proliferation. Other studies showed 
that exogenous cholesterol increases the antigen- 
presenting function of monocytes in extrinsic allergic 
alveolitis by modulating the HLA-DR region prod- 
ucts (9). It is, therefore, possible that alterations in 
the lipid composition of the lung lining fluid reported 
in these patients may have led to reduced immuno- 
suppressive properties and favoured the development 
of localized immune response and tissue damage. 
In the present patients, the foamy macrophages 
may have been the main source of the cholesterol 
crystals, as was shown in extrinsic allergic alveolitis 
(lo), and in patients suffering carmustine-induced 
pulmonary fibrosis (1). On the other hand, extra- 
cellular cholesterol crystals were associated with the 
presence of lipid-laden macrophages and smooth 
muscle cells in arteriosclerotic plaques (12). Since 
macrophage foam cells are usually more numerous 
and closer to the surface than are lipid-laden macro- 
phages (13), it is reasonable to have obtained foamy 
macrophages among cells recovered from the washed 
alveolar areas. As for the transbronchial biopsy, 
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it may be that the sample was not taken from 
distal areas which had airway disease obstruction 
associated with lipid-laden macrophages. 
In conclusion, the proteolitic enzyme activity may 
7. 
8. 
contribute to the development of severe tissue dam- 
age in susceptible regions of the lung in IPF. This 9. 
may be due to high levels of matrix-degrading pro- 
teinases (14) secreted by foamy macrophages which 
contain substantial amounts of cholesterol esters 10. 
(15). 
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